Screener
Theriva Biologics TOVX Q2 2026 earnings
Reported August 11, 2026 · Before market open
EPS-$0.07Miss by $0.02
EPS estimate-$0.06
Next report
Nov 17, 2026 (in 2 months)EPS estimate-$0.07
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Theriva Biologics report Q2 2026 earnings?
- Theriva Biologics (TOVX) reported Q2 2026 earnings on August 11, 2026 before market open.
- What were Theriva Biologics's Q2 2026 revenue and EPS?
- Theriva Biologics reported eps of $-0.07 for Q2 2026.
- Did Theriva Biologics beat estimates in Q2 2026?
- EPS missed the consensus estimate of $-0.06 by $0.02.
- How did Theriva Biologics's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 96.4% from $-1.93.
- Where can I find Theriva Biologics's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001104659-26-093782) and the 10-Q periodic report (0001104659-26-093786) directly on SEC EDGAR. The filing index links above go to sec.gov.
